Tuesday, May 3, 2016

Good time to get in on Pharmaceutical and Biotech SPDRs (XPH and XBI)?

I've been looking at SPDRs for my next long-term investment (about $4k or so) and I saw that relative to the other S&P sectors, biotech and pharm are down much more in the last year. It looks like it has hit two bottoms, once in October and once in January, but I don't know any technical details to know if this is just the beginning of a much longer slide.

What I can't figure out, however, is why the sector is driving so far down. Does anyone know any story driving this?



Submitted May 04, 2016 at 12:09AM by -Andar- http://ift.tt/26RU2Uh

No comments:

Post a Comment